Gara Jalqabaatti › Dhukkubaa Alzheimer › Michigan
Qorannoo klinikaalii Dhukkubaa Alzheimer Michigan keessatti
Qorannoo 15 Dhukkubaa Alzheimer f Michigan keessatti hirmaatuu jiru.
Magaalota Michigan keessatti
Takkalaa qorannoo (Ingiliffa)
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
- Local Institution - 1620, Troy
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 55 hanga 90 · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT06937229A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)
- Quest Research Institute, Farmington Hills
Namoota walitti qabaa jiraSadarkaa 4
Umuriin 50 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07633470A Study of LY3439539 in Participants With Alzheimer's Disease
- QUEST Research Institute, Farmington Hills
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 50 hanga 85 · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT07598370A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
- QUEST Research Institute, Farmington Hills
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 55 hanga 85 · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07589595A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- Neurobehavioral Medicine Group (NBMG), Bloomfield Township
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 55 hanga 90 · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT06585787Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
- Quest Research Institute, Farmington Hills
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 50 hanga 90 · Saalaa hunda · Haaromfame 21-Ful-2026 · NCT07177352A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
- QUEST Research Institute, Farmington Hills
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 60 hanga 85 · Saalaa hunda · Haaromfame 17-Ful-2026 · NCT06976203A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
- NeuroBehavioral Medicine Group, Bloomfield Hills
- Oakland Medical Research, Troy
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 55 hanga 90 · Saalaa hunda · Haaromfame 16-Ful-2026 · NCT07011732Evaluating Novel Healthcare Approaches to Nurturing and Caring for Hospitalized Elders
- Michigan Medicine, Ann Arbor
Namoota walitti qabaa jira
Umuriin 70 fi ol · Saalaa hunda · Haaromfame 08-Ful-2026 · NCT05929703Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
- Local Institution - 0088, Sterling Heights
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 55 hanga 90 · Saalaa hunda · Haaromfame 01-Ful-2026 · NCT06808984Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- Henry Ford Health System, Detroit
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 04-Hag-2026 · NCT06563895Michigan Healthy Mom (MI-MOM) Pregnancy Improvement Web Application Trial
- Shiawasee Health Department, Corunna
- McLaren Flint OB-GYN, Flint
- Munson Gaylord OB-GYN, Gaylord
- fi 5 dabalataa
Namoota walitti qabaa jira
Umuriin 18 fi ol · Dubartoota · Haaromfame 24-Ado-2026 · NCT07213284A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
- Revival Research Institute, LLC, Southfield
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 55 fi ol · Saalaa hunda · Haaromfame 07-Ado-2026 · NCT07602582A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD)
- QUEST Research Institute, Farmington Hills
Namoota walitti qabaa jiraSadarkaa 1Hojjettoota fayyaa simatamoo
Umuriin 45 hanga 85 · Saalaa hunda · Haaromfame 04-Wax-2026 · NCT06657768Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia
- Quest Research Institute, Farmington Hills
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 60 hanga 90 · Saalaa hunda · Haaromfame 15-Elb-2026 · NCT06584357Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.